BayMedica’s scientific founders have a rich history in the research leading to and development of a number of patented commercial products. Such products have ranged from nutraceuticals to diagnostic antigens and biopharmaceuticals made in yeast (BayMedica’s primary area of focus) to small molecule therapeutics that have successfully entered later stage clinical trials and FDA approval.